Serum metallothionein in patients with testicular cancer
- 251 Downloads
Metallothioneins (MTs) have been disclosed as a useful diagnostic factor for tumour progression and drug resistance in a variety of malignancies. Increased levels of MT in blood serum have been found in patients with several types of cancer, but there is no available information on serum MT levels in patients with testicular germ cell tumour (TGCT). The aim of the study was to determine MT levels in serum of patients with TGCT and to evaluate the portion of platinum (Pt) that binds to MT after cisplatin administration since MTs could be involved in drug resistance.
Concentration of total MT was determined in serum of 25 men with newly diagnosed TGCT by differential pulse voltammetry. The fractionation of serum was carried out by size exclusion high-performance liquid chromatography (SE-HPLC), while concentration of Pt in collected fractions was determined by inductively coupled plasma mass spectrometry.
Concentration of serum MT was significantly higher in TGCT patients than in healthy volunteers. The results of SE-HPLC analysis showed that only a small amount of Pt was bound to proteins in the area of MT elution.
Significant increase in MT levels in individuals with TGCT indicates certain health problem and, in combination with other commonly used diagnostic tools, could improve early diagnosis.
KeywordsTesticular cancer Metallothionein Platinum Serum marker
This research was supported by the Croatian Ministry of Science, Education and Sports (Grant Number 022-0222411-2408).
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in this study involving human participants were in accordance with the ethical standards of institutional ethics committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
- 5.Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER cancer statistics review, 1975–2011. National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1975_2011/. Accessed 1 Dec 2014
- 8.Vasdev N, Thorpe A (2012) Testicular germ cell tumours: a European and UK perspective. Germ cell tumor, Dr. Angabin Matin (ed), ISBN: 978-953-51-0456-8, InTech. http://www.intechopen.com/books/germ-cell-tumor/testicular-germ-cell-tumour
- 9.Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, Duca P (2006) Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 101:513–523. doi: 10.1111/j.1572-0241.2006.00467.x CrossRefPubMedGoogle Scholar
- 14.Pontes HAR, de Aquino Xavier FC, da Silva TSP, Fonseca FP, Paiva HB, Pontes FSC, Jr Dos Santos Pinto D (2009) Metallothionein and p-Akt proteins in oral dysplasia and in oral squamous cell carcinoma: an immunohistochemical study. J Oral Pathol Med 38:644–650. doi: 10.1111/j.1600-0714.2009.00787.x CrossRefPubMedGoogle Scholar
- 15.Fabrik I, Krizkova S, Huska D, Adam V, Hubalek J, Trnkova L, Eckschlager T, Kukacka J, Prusa R, Kizek R (2008) Employment of electrochemical techniques for metallothionein determination in tumor cell lines and patients with a tumor disease. Electroanalysis 20:1521–1532. doi: 10.1002/elan.200704215 CrossRefGoogle Scholar
- 16.Krejcova L, Fabrik I, Hynek D, Krizkova S, Gumulec J, Ryvolova M, Adam V, Babula P, Trnkova L, Stiborova M, Hubalek J, Masarik M, Binkova H, Eckschlager T, Kizek R (2012) Metallothionein electrochemically determined using Brdicka reaction as a promising blood marker of head and neck malignant tumours. Int J Electrochem Sci 7:1767–1784Google Scholar
- 23.Martinčič A, Cemazar M, Sersa G, Kovač V, Milačič R, Ščančar J (2013) A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection. Talanta 116:141–148. doi: 10.1016/j.talanta.2013.05.016 CrossRefPubMedGoogle Scholar
- 25.Peleg-Shulman T, Najajreh Y, Gibson D (2002) Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles. J Inorg Biochem 91:306–311CrossRefPubMedGoogle Scholar
- 26.Hsu M, Wang W, Li L (2014) Lower level of serum metallothionein I/II in patients with atopic dermatitis. Austin J Dermatol 1:2–3Google Scholar
- 28.Krizkova S, Fabrik I, Adam V, Kukacka J, Prusa R, Chavis GJ, Trnkova L, Strnadel J, Horak V, Kizek R (2008) Utilizing of adsorptive transfer stripping technique Brdicka reaction for determination of metallothioneins level in melanoma cells, blood serum and tissues. Sensors 8:3106–3122. doi: 10.3390/s8053106 CrossRefPubMedCentralGoogle Scholar
- 32.Chin JL, Banerjee D, Kadhim SA, Kontozoglou TE, Chauvin PJ, Cherian MG (1993) Metallothionein in testicular germ cell tumors and drug resistance. Clin Correl Cancer 72:3029–3035Google Scholar
- 40.Huska D, Fabrik I, Baloun J, Adam V, Masarik M, Hubalek J, Vasku A, Trnkova L, Horna A, Zeman L, Kizek R (2009) Study of interactions between metallothionein and cisplatin by using differential pulse voltammetry Brdicka reaction and quartz crystal microbalance. Sensors 9:1355–1369. doi: 10.3390/s90301355 CrossRefPubMedCentralPubMedGoogle Scholar
- 41.Ossipov K, Scaffidi-Domianello YY, Seregina IF, Galanski M, Keppler BK, Timerbaev AR, Bolshov MA (2014) Inductively coupled plasma mass spectrometry for metallodrug development: albumin binding and serum distribution of cytotoxic cis- and trans-isomeric platinum(II) complexes. J Inorg Biochem 137:40–45. doi: 10.1016/j.jinorgbio.2014.04.008 CrossRefPubMedGoogle Scholar